Jan 8, 2026
How effective are antivirals this season against H3N2 subclade K, and when should high‑risk patients seek treatment?
Multiple independent surveillance and laboratory reports find that H3N2 subclade K remains susceptible to the licensed influenza antivirals now in clinical use, even as the variant has antigenically d...